Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.

Jeffrey Posner is a Nephrologist in Owings Mills, Maryland. Dr. Posner is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease. Dr. Posner is currently accepting new patients.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young.

Eric Brown is a Nephrologist in Owings Mills, Maryland. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Acute Kidney Failure. Dr. Brown is currently accepting new patients.

Joel Lahn is a Nephrologist in Owings Mills, Maryland. Dr. Lahn is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Renovascular Hypertension, Acute Kidney Failure, Nephrosclerosis, and End-Stage Renal Disease (ESRD).

Sonal Korgaonkar is a Nephrologist in Owings Mills, Maryland. Dr. Korgaonkar is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD). Dr. Korgaonkar is currently accepting new patients.

Manju Mavanur is a Nephrologist and a Hospital Medicine provider in Owings Mills, Maryland. Dr. Mavanur is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, End-Stage Renal Disease (ESRD), and Kidney Transplant. Dr. Mavanur is currently accepting new patients.

Anitha Nallu is a Nephrologist in Owings Mills, Maryland. Dr. Nallu is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Low Sodium Level. Dr. Nallu is currently accepting new patients.

Leonid Klopouh is a Nephrologist in Owings Mills, Maryland. Dr. Klopouh is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Acute Kidney Failure, and Chronic Kidney Disease. Dr. Klopouh is currently accepting new patients.

Hillary Barnes is an Endocrinologist in Reisterstown, Maryland. Dr. Barnes has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Osteoporosis, Postmenopausal Osteoporosis, and Diabetic Nephropathy.

Dr. Derek M. Fine is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include glomerular kidney disease, particularly lupus nephritis and other immune-mediated kidney diseases, HIV-related kidney disease, scleroderma-related kidney disease, acute kidney injury, hyponatremia, kidney biopsy, and rhabdomyolysis. Dr. Fine earned his M.D. at Johns Hopkins. He completed his residency in internal medicine and his fellowship in nephrology at Johns Hopkins. His research interests include HIV-related kidney diseases and lupus nephritis. He is a member of the Miller Coulson Academy of Clinical Excellence and was named 2018 Physician of the Year at Johns Hopkins Hospital. Dr. Fine is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Lupus Nephritis, Glomerulonephritis, Systemic Lupus Erythematosus (SLE), Chronic Kidney Disease, and Kidney Transplant.

Dr. Scott Pilla earned his M.D. at Robert Wood Johnson Medical School and completed his residency at Johns Hopkins Bayview Medical Center. He completed the Johns Hopkins General Internal Medicine Fellowship in clinical research in 2018. Dr. Pilla is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Obesity.

Dr. Rameen J. Molavi is part-time on the medical faculty as an instructor in medicine in the division of General Internal Medicine within the Department of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is internal medicine. Dr. Molavi is also the managing physician and chair of Park Medical Associates, a member of Johns Hopkins Regional Physicians. He is the recipient of the 2025 Samuel P. Asper Award for excellence in medicine from the Maryland Chapter of the American College of Physicians. Dr. Molavi holds a B.A. in biology from Rice University in Houston, TX. He earned his M.D. at the Johns Hopkins University School of Medicine. He completed his internship and residency in categorical internal medicine at the Washington University School of Medicine Barnes-Jewish Hospital in St. Louis, MO. He began medical practice in Lutherville in 1999 and joined Park Medical Associates in 2009. His practice focus is on primary care for adults of all ages. Recent News Articles and Media Coverage Dr. Rameen Molavi: COVID-19 Testing Realities, WYPR (April 28, 2020) Samuel Asper Award, American College of Physicians (2025). Dr. Molavi is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Mesenteric Venous Thrombosis, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension.

Akshay Amin is a Nephrologist in Lutherville, Maryland. Dr. Amin is rated as a Distinguished provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and Diabetic Nephropathy. Dr. Amin is currently accepting new patients.

Colleen Leavitt, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians. She received her medical degree and completed her residency in medicine & pediatrics at Loyola University School of Medicine. Dr. Leavitt is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Latrica Cook is a primary care provider, practicing in Internal Medicine in Owings Mills, Maryland. Dr. Cook is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. Her top areas of expertise are Coffin-Siris Syndrome, Langer Mesomelic Dysplasia, Cornelia De Lange Syndrome, and Russell-Silver Dwarfism. Dr. Cook is currently accepting new patients.

Elliot Rothschild is a primary care provider, practicing in Internal Medicine in Owings Mills, Maryland. Dr. Rothschild is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Type 2 Diabetes (T2D). Dr. Rothschild is currently accepting new patients.

Mahmudul Haque is a Nephrologist in Owings Mills, Maryland. Dr. Haque is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Acute Kidney Failure, Renovascular Hypertension, Nephrosclerosis, and Chronic Kidney Disease. Dr. Haque is currently accepting new patients.

Daniel Corning is a Nephrologist in Owings Mills, Maryland. Dr. Corning is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are Renovascular Hypertension, Nephrosclerosis, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD). Dr. Corning is currently accepting new patients.

Ira Mandell is a Nephrologist in Owings Mills, Maryland. Dr. Mandell is rated as an Experienced provider by MediFind in the treatment of Diabetic Nephropathy. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Nephrosclerosis, and Renovascular Hypertension.